会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Method and system of measuring anatomical features in subcutaneous images to assess risk of injury
    • 测量皮下图像解剖特征的方法和系统,以评估损伤风险
    • US09078621B2
    • 2015-07-14
    • US14074980
    • 2013-11-08
    • BAYLOR UNIVERSITYSCOTT & WHITE HEALTHCARE
    • Brian A. GarnerChristopher ChaputJacob Hoffman
    • G06T7/00A61B5/00G06T7/60
    • A61B6/5217A61B5/4504A61B6/032A61B6/505G06T7/0012G06T7/0014G06T7/60G06T2207/10081G06T2207/30012
    • The present disclosure provides a method and system using software and associated equipment to automatically identify two or more preselected anatomical features by examining pixels within images such as computerized tomography (CT) scanned images, determining appropriate measurements between such identified features based on dimensions and scaling available within the image file, comparing these measurements to normative data, and providing output of the results to a user, such as medical personnel. In at least one embodiment, system can measure the basion-dens interval (BDI), which has been shown to be an effective indicator of ligament injury within the occipito-cervical complex (“OCC”) that may not present with other symptoms, is not revealed with standard CT imaging, and is of mortal danger to the patient if untreated. The system can automate interpreting CT scanned images and alert medical personnel about the risk of OCC ligament damage.
    • 本公开提供了一种使用软件和相关联的设备的方法和系统,通过检查诸如计算机断层摄影(CT)扫描图像的图像内的像素来自动识别两个或更多个预先选择的解剖特征,基于尺寸和可用尺度来确定在所识别的特征之间的适当测量 在图像文件内,将这些测量与规范数据进行比较,并将结果的输出提供给诸如医务人员的用户。 在至少一个实施例中,系统可以测量已经显示为可能不存在于其他症状的枕骨 - 颈部复合体(“OCC”)内的韧带损伤的有效指标的基底间隔(BDI) 不能用标准的CT成像显示,如果未经治疗则对患者造成致命的危险。 该系统可以自动解释CT扫描图像,并向医务人员报告OCC韧带损伤的风险。
    • 7. 发明申请
    • METHOD AND SYSTEM OF MEASURING ANATOMICAL FEATURES IN SUBCUTANEOUS IMAGES TO ASSESS RISK OF INJURY
    • 测量不规则图像中的解剖特征以评估伤害风险的方法和系统
    • US20140133726A1
    • 2014-05-15
    • US14074980
    • 2013-11-08
    • SCOTT & WHITE HEALTHCAREBAYLOR UNIVERSITY
    • Brian A. GARNERChristopher CHAPUTJacob HOFFMAN
    • A61B5/00G06T7/00
    • A61B6/5217A61B5/4504A61B6/032A61B6/505G06T7/0012G06T7/0014G06T7/60G06T2207/10081G06T2207/30012
    • The present disclosure provides a method and system using software and associated equipment to automatically identify two or more preselected anatomical features by examining pixels within images such as computerized tomography (CT) scanned images, determining appropriate measurements between such identified features based on dimensions and scaling available within the image file, comparing these measurements to normative data, and providing output of the results to a user, such as medical personnel. In at least one embodiment, system can measure the basion-dens interval (BDI), which has been shown to be an effective indicator of ligament injury within the occipito-cervical complex (“OCC”) that may not present with other symptoms, is not revealed with standard CT imaging, and is of mortal danger to the patient if untreated. The system can automate interpreting CT scanned images and alert medical personnel about the risk of OCC ligament damage.
    • 本公开提供了一种使用软件和相关联的设备的方法和系统,通过检查诸如计算机断层摄影(CT)扫描图像的图像内的像素来自动识别两个或更多个预先选择的解剖特征,基于尺寸和可用尺度来确定在所识别的特征之间的适当测量 在图像文件内,将这些测量与规范数据进行比较,并将结果的输出提供给诸如医务人员的用户。 在至少一个实施例中,系统可以测量已经显示为可能不存在于其他症状的枕骨 - 颈部复合体(“OCC”)内的韧带损伤的有效指标的基底间隔(BDI) 不能用标准的CT成像显示,如果未经治疗则对患者造成致命的危险。 该系统可以自动解释CT扫描图像,并向医务人员报告OCC韧带损伤的风险。
    • 10. 发明申请
    • METHOD OF DIAGNOSING AND THERAPEUTICALLY TREATING A PATIENT FOR A TRAUMATIC BRAIN INJURY
    • 诊断和治疗TRAUMATIC脑损伤的患者的方法
    • US20110319372A1
    • 2011-12-29
    • US13160735
    • 2011-06-15
    • JULES B. PUSCHETTLEE SHAPIRO
    • JULES B. PUSCHETTLEE SHAPIRO
    • A61K31/58A61P25/00G01N33/566
    • G01N33/53A61K31/585G01N33/743G01N2800/28G01N2800/40
    • Known or suspected traumatic brain injuries may be treated therapeutically by administering a therapeutically effective dose of resibufogenin. A preferred method for determining if a patient has a traumatic brain injury includes obtaining a body specimen from the patient, determining the concentration of marinobufagenin in the body specimen, comparing the concentration of marinobufagenin to the concentration in such body specimens in normal patients, and if the marinobufagenin concentration is substantially above the concentration of a normal patient, concluding traumatic brain injury exists. In a preferred embodiment, a substantial elevation is deemed to be an increase of about 30 percent above the marinobufagenin concentration of a normal patient. The body specimen may be blood, urine, or cerebrospinal fluid. If a substantial elevation is deemed to exist, the magnitude of the departure from the concentration of a normal patient may be employed in determining the timing and nature of treatment provided to the patient. The method may be repeated at predetermined intervals to monitor changes in the marinobufagenin with time.
    • 可以通过施用治疗有效剂量的抗纤维蛋白原治疗来治疗已知或怀疑的创伤性脑损伤。 用于确定患者是否具有创伤性脑损伤的优选方法包括从患者获得身体标本,确定身体标本中海马素原基因的浓度,将正常患者中的马氏原虫基因的浓度与这些身体标本中的浓度进行比较,以及如果 造血干细胞因子浓度明显高于正常患者的浓度,结论存在创伤性脑损伤。 在优选的实施方案中,认为实质高程比普通患者的海因素原基因浓度高出约30%。 身体标本可能是血液,尿液或脑脊液。 如果认为存在实质性高程,则在确定提供给患者的治疗的时间和性质时可以采用偏离正常患者浓度的大小。 可以以预定的间隔重复该方法以随时间监测马铃薯白蛋白原的变化。